Using tocilizumab off-label in four young adults with sickle cell disease (SCD) who developed hyperhemolysis syndrome as a complication…
Articles by Margarida Maia, PhD
Most Gambian children with sickle cell anemia — the most common and severe form of sickle cell disease (SCD)…
The first participant with sickle cell disease (SCD) has been dosed in a clinical trial of HBI-002, an…
A student at Kennesaw State University in Georgia is helping to develop a low-cost, light-based device to screen for stroke…
A camp in North Carolina offers children living with sickle cell disease the chance to build confidence, independence, and…
The first healthy volunteer has been dosed in a Phase 1 clinical study of CLY-124 — a novel oral small…
Adults with sickle cell disease (SCD) who are started on buprenorphine to ease chronic pain — either in a…
Hydroxyurea, an approved medication to reduce the frequency of pain crises associated with sickle cell disease (SCD),…
An ongoing, early-phase clinical trial of pociredir, an oral small molecule being developed by Fulcrum Therapeutics as a possible…
Vascarta is launching a proof-of-concept Phase 1 clinical study to test its topical curcumin gel VAS-101 — which uses a…